/PRNewswire/ IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today.
IRRAS Announces Notified Body Transition from GMED to DEKRA, a Global Leader in Inspection and Certifications
News provided by
Share this article
Share this article
STOCKHOLM, May 11, 2021 /PRNewswire/ IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, announced today that the CE Mark certificates for its IRRA
flow system and the company s ISO13485:2016 certification have been transferred to a new notified body, DEKRA. After the successful completion of a recent audit by DEKRA, these CE Mark certificates for IRRA
flow will
remain valid until May 2024. With DEKRA, we are building a relationship with one of the largest, most respected notified bodies in the world, said Will Martin, President and Chief Commercial Officer of IRRAS. DEKRA has resources in place near our US headquarters in Southern California, so important regulatory work has continued despite Covid-19. We believe that this tr
Published: May 03, 2021
SAN DIEGO, May 3, 2021 /PRNewswire/ Shoreline Biosciences, Inc. (Shoreline), a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized and targeted natural killer (NK) and Macrophage cellular immunotherapies derived from induced pluripotent stem cells (iPSC) for cancer and other serious diseases, today announced the appointment of Vanessa L. Jacoby as Chief Financial Officer. Ms. Jacoby brings more than twenty years of experience as a financial leader to Shoreline, with a strong background in company building and financial strategy. I am pleased to welcome Vanessa to Shoreline as our Chief Financial Officer, said Kleanthis G. Xanthopoulos, Ph.D., Shoreline Co-Founder and Executive Chairman. Vanessa s recent IPO and public markets experience, coupled with a proven track record in building and financing companies through critical phases of growth, will be invaluable to our team as we grow into a domain-do
IRRAS AB publishes Interim Report for the period January to March 2021
Meaningful Commercial Acceleration Seen Globally
News provided by
Share this article
STOCKHOLM, May 4, 2021 /PRNewswire/ During Q1, the global installed base for IRRAS products increased; the total number of IRRAflow systems increased from 73 to 84 and Hummingbird systems grew from 5 to 9. An increase in the number of systems shipped is important, but it is more critical to convert evaluations into revenue-generating commercial customers. During the quarter, two influential US comprehensive stroke centers, Buffalo General Medical Center and West Virginia University, placed commercial disposable stocking orders for IRRAflow. The contracts signed by these customers more than doubled the number of commercial IRRAflow control units (from 9 to 19) and will generate recurring revenue as usage continues.
IRRAS AB publishes Interim Report for the period January to March 2021 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.